{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:01:02Z","timestamp":1790661662127,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T00:00:00Z","timestamp":1353369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00520-012-1630-5","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T03:55:50Z","timestamp":1353297350000},"page":"1097-1103","source":"Crossref","is-referenced-by-count":98,"title":["Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison"],"prefix":"10.1007","volume":"21","author":[{"given":"Kristin M.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pinilla-Ibarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Sotomayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather S. L.","family":"Jim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent J.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomir","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lancet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tinsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Komrokji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,20]]},"reference":[{"issue":"11","key":"1630_CR1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","volume":"348","author":"SG O'Brien","year":"2003","unstructured":"O'Brien SG, Guilhot F, Larson RA et al (2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348(11):994\u20131004","journal-title":"N Engl J Med"},{"issue":"11","key":"1630_CR2","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1200\/JCO.2003.12.154","volume":"21","author":"EA Hahn","year":"2003","unstructured":"Hahn EA, Glendenning GA, Sorensen MV et al (2003) Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study. J Clin Oncol 21(11):2138\u20132146","journal-title":"J Clin Oncol"},{"issue":"6","key":"1630_CR3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3109\/10428194.2011.560310","volume":"52","author":"Z Aziz","year":"2011","unstructured":"Aziz Z, Iqbal J, Aaqib M et al (2011) Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia. Leuk Lymphoma 52(6):1017\u20131023","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"1630_CR4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11899-010-0045-y","volume":"5","author":"M Agrawal","year":"2010","unstructured":"Agrawal M, Garg RJ, Cortes J et al (2010) Tyrosine kinase inhibitors: the first decade. Curr Hematol Malig Rep 5(2):70\u201380","journal-title":"Curr Hematol Malig Rep"},{"issue":"4","key":"1630_CR5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cncr.25648","volume":"117","author":"J Pinilla-Ibarz","year":"2011","unstructured":"Pinilla-Ibarz J, Cortes J, Mauro MJ (2011) Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: definitions and clinical implications. Cancer 117(4):688\u2013697","journal-title":"Cancer"},{"issue":"17","key":"1630_CR6","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood-2011-04-347575","volume":"118","author":"F Efficace","year":"2011","unstructured":"Efficace F, Baccarani M, Breccia M et al (2011) Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population. Blood 118(17):4554\u20134560","journal-title":"Blood"},{"issue":"11","key":"1630_CR7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0895-4356(98)00094-8","volume":"51","author":"G Apolone","year":"1998","unstructured":"Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51(11):1025\u20131036","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"1630_CR8","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/cncr.22993","volume":"110","author":"PB Jacobsen","year":"2007","unstructured":"Jacobsen PB, Donovan KA, Small BJ et al (2007) Fatigue after treatment for early stage breast cancer: a controlled comparison. Cancer 110(8):1851\u20131859","journal-title":"Cancer"},{"issue":"4","key":"1630_CR9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1008842517972","volume":"7","author":"DM Hann","year":"1998","unstructured":"Hann DM, Jacobsen PB, Azzarello LM et al (1998) Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res 7(4):301\u2013310","journal-title":"Qual Life Res"},{"issue":"5","key":"1630_CR10","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.1998.16.5.1689","volume":"16","author":"JA Broeckel","year":"1998","unstructured":"Broeckel JA, Jacobsen PB, Horton J et al (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16(5):1689\u20131696","journal-title":"J Clin Oncol"},{"issue":"5","key":"1630_CR11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jpainsymman.2007.11.013","volume":"36","author":"KA Donovan","year":"2008","unstructured":"Donovan KA, Jacobsen PB, Small BJ et al (2008) Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory. J Pain Symptom Manage 36(5):480\u2013487","journal-title":"J Pain Symptom Manage"},{"key":"1630_CR12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385\u2013401","journal-title":"Appl Psychol Meas"},{"issue":"5","key":"1630_CR13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0022-3999(99)00004-5","volume":"46","author":"D Hann","year":"1999","unstructured":"Hann D, Winter K, Jacobsen P (1999) Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46(5):437\u2013443","journal-title":"J Psychosom Res"},{"issue":"2","key":"1630_CR14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193\u2013213","journal-title":"Psychiatry Res"},{"issue":"1","key":"1630_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-3999(97)00298-5","volume":"45","author":"JS Carpenter","year":"1998","unstructured":"Carpenter JS, Andrykowski MA (1998) Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 45(1):5\u201313","journal-title":"J Psychosom Res"},{"issue":"2","key":"1630_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpainsymman.2003.12.002","volume":"27","author":"SL Beck","year":"2004","unstructured":"Beck SL, Schwartz AL, Towsley G et al (2004) Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage 27(2):140\u2013148","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"1630_CR17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y","volume":"89","author":"VT Chang","year":"2000","unstructured":"Chang VT, Hwang SS, Feuerman M et al (2000) The memorial symptom assessment scale short form (MSAS-SF). Cancer 89(5):1162\u20131171","journal-title":"Cancer"},{"key":"1630_CR18","volume-title":"SF-36 health survey: Manual and interpretation guide","author":"J Ware","year":"1993","unstructured":"Ware J (1993) SF-36 health survey: Manual and interpretation guide. The Health Institute, New England Medical Center, Boston"},{"key":"1630_CR19","volume-title":"SF-36 pysical and mental health summary scales: A user's manual","author":"JE Ware","year":"1994","unstructured":"Ware JE, Kosinski M, Keller SD (1994) SF-36 pysical and mental health summary scales: A user's manual. The Health Institute, New England Medical Center, Boston"},{"key":"1630_CR20","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates"},{"issue":"7","key":"1630_CR21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jnci\/djr060","volume":"103","author":"C Gambacorti-Passerini","year":"2011","unstructured":"Gambacorti-Passerini C, Antolini L, Mahon FX et al (2011) Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib. J Natl Cancer Inst 103(7):553\u2013561","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"1630_CR22","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","volume":"362","author":"G Saglio","year":"2010","unstructured":"Saglio G, Kim DW, Issaragrisil S et al (2010) Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 362(24):2251\u20132259","journal-title":"N Engl J Med"},{"key":"1630_CR23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-8722-2-46","volume":"2","author":"D Masiello","year":"2009","unstructured":"Masiello D, Gorospe G 3rd, Yang AS (2009) The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib. J Hematol Oncol 2:46","journal-title":"J Hematol Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1630-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-012-1630-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1630-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:04:21Z","timestamp":1559081061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-012-1630-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,20]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["1630"],"URL":"https:\/\/doi.org\/10.1007\/s00520-012-1630-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,20]]}}}